Filing Details
- Accession Number:
- 0001127602-13-015531
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-03 16:33:25
- Reporting Period:
- 2013-05-02
- Filing Date:
- 2013-05-03
- Accepted Time:
- 2013-05-03 16:33:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1022079 | Quest Diagnostics Inc | DGX | Services-Medical Laboratories (8071) | 161387862 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1018538 | R Gail Wilensky | C/O Quest Diagnostics Incorporated 3 Giralda Farms Madison NJ 07940 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-05-02 | 10,000 | $55.40 | 23,952 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-05-02 | 10,000 | $57.20 | 13,952 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2013-05-02 | 10,000 | $0.00 | 10,000 | $55.40 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2013-05-04 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple purchases at prices ranging from $57.19 to $57.22. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The options vested in three equal annual installments beginning on the first annual anniversary of the grant date.